What specific respiratory conditions or symptoms is Bronchokod intended to treat?

Bronchokod is intended to treat bronchospasm and breathing difficulties associated with asthma, chronic obstructive pulmonary disease (COPD), and other obstructive airway diseases.

What safety warnings or potential side effects should users be aware of when taking Bronchokod?

Common side effects include tremor, palpitations, headache, and dry mouth; it should be used cautiously in patients with heart disease, high blood pressure, hyperthyroidism, or arrhythmias, and it is contraindicated in individuals with known hypersensitivity to its ingredients.

Is the packaging of Bronchokod recyclable and are there any special disposal considerations for the medication?

Bronchokod is packaged in a cardboard box with a recyclable blister pack; unused tablets should be discarded according to local pharmaceutical waste guidelines to minimize environmental impact.

SANOFI • 1

Bronchokod

Health Beauty

Product Insights

Bronchokod, manufactured by Sanofi, is a pharmaceutical product intended to relieve bronchial constriction and improve breathing in individuals with respiratory disorders. Its formulation provides rapid bronchodilation, making it effective for acute asthma attacks and COPD exacerbations, but it may cause side effects such as tremor, palpitations, and headaches, especially in patients with cardiovascular conditions. The medication is sold in France and complies with local regulatory standards, offering a trusted therapeutic option for clinicians addressing airway obstruction.

Comparative Analysis

In the competitive market of respiratory therapeutics, Bronchokod distinguishes itself through Sanofi’s proprietary bronchodilator formulation that delivers swift relief of bronchospasm, positioning it as a preferred choice for healthcare professionals managing asthma and COPD.

84%

35%